Clinical Trials Browser

Phase 3 × Papillomavirus Infections × Blood Specimen Collection × Clear all

NCT00947115 2020-10-30

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects

Phase 3 Completed

525 enrolled 24 charts

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00877877 2020-01-18

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

Phase 3 Completed

632 enrolled 28 charts

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT02100618 2015-07-20

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Phase 3 Withdrawn

Papillomavirus Infections